SCHEMBL8538130

SCHEMBL8538130

CSCc1cc(OCc2ccccc2)ccc1-c1ncc[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.43
MAOA P21397 3/20 0.43
MAPT P10636 3/20 0.42
MAPK1 P28482 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HSP90AA1 P07900 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NSD2 O96028 1/20 0.42
ABL1 P00519 1/20 0.42
PPARG P37231 1/20 0.42
RIN1 Q13671 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
TOP1 P11387 1/20 0.41
NOD2 Q9HC29 1/20 0.41
HTR1D P28221 2/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
ALOX5 P09917 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539649 0.82 NOS3 (0.47) KDM4ECYP3A4
SCHEMBL8536462 0.81 CYP1A2 (0.44) MAPTMAPK1NPSR1KDM4EPPARG
SCHEMBL10922444 0.79 MAPT (0.50) MAOBMAOAMAPTMAPK1NPSR1
SCHEMBL8535625 0.79 NISCH (0.49) KDM4ECYP3A4
SCHEMBL8540790 0.78 NISCH (0.37) KDM4ECYP3A4
SCHEMBL8537087 0.78 CSNK1A1 (0.45) CYP3A4
SCHEMBL8536816 0.77 JAK2 (0.47) KDM4ECYP3A4
SCHEMBL8541400 0.74 MC4R (0.37) MAPTMAPK1KDM4ECYP3A4
SCHEMBL8540730 0.74 MC4R (0.46) CYP3A4
SCHEMBL8540597 0.74 CSNK1A1 (0.36) MAPTKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed